Vamorolone is a synthetic steroid, which is under development for the treatment of duchenne muscular dystrophy.
Anti-inflammatory drugs of the corticosteroid class show a carbonyl or hydroxyl group on the C11 carbon of the steroid backbone.The lack of deleterious changes in bone turnover markers in patients with DMD treated with vamorolone suggests a possible loss of bone morbidities typically associated with glucocorticoidsGlucocorticoid treatment is the most common cause of osteoporosis; fractures occur in 30% to 50% of patients with DMD receiving long-term therapy.27
A recent retrospective study of an inception cohort of 403,337 patients newly diagnosed with rheumatoid arthritis, asthma/chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, lupus, and sarcoidosis found 72% to be prescribed glucocorticoids (52% at age <50 years).28 Use of glucocorticoids was strongly associated with increased rate of fractures,
A novel dissociative steroidal anti-inflammatory drug, vamorolone, showed evidence of efficacy and reduction of safety concerns typically seen with traditional glucocorticoids in a 48-patient, open-label, exploratory, multiple-ascending-dose study in young patients with DMD.
———————————-
So comparing it to ATL1102..Vamorolone a dissociative steroid still has a great deal of side effects although not as much as corticosteroids... (bone fractures)
Vamorolone is for young DMD patients (4-7 yrs old )
Atl1102 has No side effects...
Hope that helps Mispec..
- Forums
- ASX - By Stock
- PER
- How does ATL1102 compare with Vamorolone
How does ATL1102 compare with Vamorolone, page-2
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
0.002(2.35%) |
Mkt cap ! $78.43M |
Open | High | Low | Value | Volume |
8.6¢ | 8.9¢ | 8.5¢ | $53.40K | 614.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 67263 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49999 | 0.087 |
2 | 500872 | 0.085 |
2 | 262571 | 0.084 |
1 | 10000 | 0.083 |
2 | 120000 | 0.082 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 67263 | 1 |
0.090 | 546175 | 2 |
0.091 | 108000 | 1 |
0.092 | 135429 | 2 |
0.093 | 175642 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online